Dr Abdul-Wahid Mohammad


CardioMetabolic Diabetes Services Impact on the Achievement of National Diabetes Audit Outcomes in Primary Care

 

The Inspirational Bytes are here for you to support the sharing of evidence-based interventions. The aim of these 'Byte Size' meetings is to help reduce the negative effects diabetes can potentially cause to your patients and their families.

 

Interested? Get in touch with your Sanofi contact person for more details on the session. The meetings are 30 minutes with an optional 30 minute Q&A.

These promotional meetings are organised and funded by Sanofi.

Get In Touch

 

 

About Dr Abdul Wahid

Abdul-Wahid Mohammad

Dr Abdul-Wahid Mohammad is a pioneering portfolio pharmacist with a PhD in the design and implementation of new models of healthcare. With over 18 years of experience in the healthcare sectors of pharmacy and primary care, he has delivered innovation in service delivery for crucial NHS stakeholders and organisations. These opportunities have allowed the fulfilment of his primary goal to empower NHS organisations and thought leaders to differentiate themselves from the status quo and drive measurable results through ground breaking clinical, financial, and patient outcomes.

Abdul-Wahid is currently a non-executive director for Medway Practice Alliance LTD, GP Federation and a sessional lecturer at Canterbury  Christchurch University for Non-Medical Prescribing. He is pharmacy workstream lead for the Kent and Medway Sustainability and Transformation Partnership Diabetes Oversight committee.

Alongside he is a keen researcher, speaker, teacher and mentor in all things Pharmacy,  Pharmaceutical Care and Diabetes. He is also a recognised national speaker in these subjects. His other interests include nutrition and fitness, and most importantly spending time with his wonderful wife and two beautiful daughters. 

Throughout his career, Abdul-Wahid has worked with numerous organisations across a wide range of sectors and implemented new service delivery models which have generated outstanding clinical, and financial outcomes.

 

Interested in running or joining this session?

Reach out to your Sanofi contact person. Together you can discuss next steps.

 

Get In Touch


lady speaking on phone
Always up to date?

Webinars, evidence, expert videos, peer-to-peer events... Do you want to be the first to know when new, relevant information is available? Let us know and we'll send you a message.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to the Sanofi drug safety department on 0800 0902 314. Alternatively, send via email to UK-drugsafety@sanofi.com. Prescribing information will be available at the meeting.
This site uses cookies to store information on your computer. Some cookies on this site are needed because the site won’t work as expected without them. To learn more about cookies, please read our Cookie Policy.
By closing this message or using the website, you agree to our use of cookies on this device in agreement with our Cookie Policy, unless you have turned them off.
Accept and close